Is SciClone Pharmaceuticals, stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, SciClone Pharmaceuticals, pays dividends. Last time was Wednesday 28th of June 2023 where the investors holding the stock on Friday 2nd of June 2023 were paid HKD0.39 per share. Over the last 2 times between 2022 and 2023, SciClone Pharmaceuticals, has paid HKD0.74 with an average of HKD0.37 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for SciClone Pharmaceuticals, 10 years ago, but if you had invested on Wednesday 3rd of March 2021 when the price was HKD18.80, you would have made a loss of HKD-0.0800 per share or -0.43%
Yes, the average daily trading liquidity for SciClone Pharmaceuticals, is HKD3.13 million. You should therefore be able to get in and out of your positions relatively fast.
SciClone Pharmaceuticals, has no real debt, which is good in periods of high inflation. With a high cash flow to debt ratio of 42.77, the company's ability to pay off the debt is good. SciClone Pharmaceuticals, has a very good net profit margin of 35.55% and should have very high tolerances against inflation.
We have calculated the inflation risk for SciClone Pharmaceuticals, to be low [0 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.